Diagnos Laboratorium Utama Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Yanaprima Hastapersada Tbk trades at Rp600 (market cap 397.46B, 16.1K 24h volume). The key difference: Yanaprima Hastapersada Tbk is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 16.1K). Which is the better fit depends on your goals.
| DGNS | YPAS | |
|---|---|---|
Market Cap | 310.75B | 397.46B |
Volume | 963.6K | 16.1K |
Lot | 9.64K | 161 |
Turnover | 217.67M | 9.82M |
Average Price | 225.89 | 609.91 |
Value | 217.67M | 9.82M |
Indicative Equilibrium Price | 226 | 600 |
Indicative Equilibrium Volume | 1K | 3 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Read more on YPAS →